Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.
Chevalier MF, Petitjean G, Dunyach-Rémy C, Didier C, Girard PM, Manea ME, Campa P, Meyer L, Rouzioux C, Lavigne JP, Barré-Sinoussi F, Scott-Algara D, Weiss L. Chevalier MF, et al. Among authors: didier c. PLoS Pathog. 2013;9(6):e1003453. doi: 10.1371/journal.ppat.1003453. Epub 2013 Jun 20. PLoS Pathog. 2013. PMID: 23818854 Free PMC article. Clinical Trial.
Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy.
Weiss L, Chevalier MF, Assoumou L, Paul JL, Alhenc-Gelas M, Didier C, Taibi S, Manea EM, Campa P, Girard PM, Costagliola D; IMEA 043-CESAR trial working group. Weiss L, et al. Among authors: didier c. J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):390-8. doi: 10.1097/QAI.0000000000000879. J Acquir Immune Defic Syndr. 2016. PMID: 26536319 Clinical Trial.
117 results